The article claims that Australian health authorities were aware by 2021 that mRNA vaccine nanoparticles disperse beyond the injection site, reaching vital organs such as the liver, brain, and ovaries. This conclusion, derived from internal regulatory documents and external studies, suggests a lack of transparency regarding the systemic distribution of vaccine components. The implication is that regulatory bodies prioritized rapid approval despite known data on biodistribution, raising concerns about the adequacy of initial risk assessments and public communication. Further asserting significant health risks, the text links mass vaccination campaigns to increased cancer mortality rates in Japan. It argues that the surge in deaths from various cancers, particularly among older demographics receiving multiple doses, cannot be explained by pandemic-related healthcare disruptions alone. This narrative implies a causal relationship between widespread mRNA vaccination and adverse long-term health outcomes, challenging the perceived safety profile of these medical interventions. This content is relevant to open_data discussions as it highlights the potential for Freedom of Information requests to uncover non-public regulatory insights. It underscores the importance of data transparency in public health, illustrating how accessing internal reports can fuel public debate and scrutiny over governmental decision-making processes. The case exemplifies the tension between official narratives and independently sourced data, emphasizing the role of open information in holding authorities accountable for medical safety approvals.
Source: naturalnews.comPublished on 2024-06-28
Related news
- German CDC Documents Show Politics Drove Covid Response, Not Science - LewRockwell
- Biden admin. delays records release on how much it spends promoting LGBT ideology abroad: lawsuit
- Coinbase sues SEC, FDIC for information relating to crypto regulation
- Public bodies 'over reliant' on external legal advisors